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ABSTRACT
Background: Antiphospholipid syndrome (APS), a complex autoimmune disorder, is
associated with thromboembolic events and 7%-25% of unexplained fetal losses. No research
exists on perinatal nurses’ knowledge of APS or its nursing management.
Purpose: To assess perinatal nurses’ knowledge and nursing management of pregnant women
with APS. This pilot study also may justify a study with a larger sample size and more
recruitment sites, as well as determine the need for an educational program on APS for perinatal
nurses.
Methodology: This is a descriptive cross-sectional pilot study. Ninety-two registered nurses
working in perinatal areas from a metropolitan medical center in the Southeastern United States
completed a 20-item survey on demographics and knowledge about APS and nursing
management of patients with APS.
Analyses: Descriptive statistics were conducted to characterize the sample. ANOVA, t tests,
Pearson’s correlation, and logistic regression were used to determine factors associated with
knowledge of APS and its nursing management.
Conclusion: The average score of participants on the 8 knowledge items of the survey was
1.4. Only current work area was associated with knowledge scores, however, previous
familiarity with APS was associated with higher scores.
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INTRODUCTION
Antiphospholipid Syndrome (APS), also known as Hughes Syndrome, is the most common
cause of acquired thrombophilia. The syndrome is characterized by recurrent thromboembolic
events and/or pregnancy loss in the presence of persistent laboratory evidence for
antiphospholipid antibodies (aPLs)—lupus anticoagulant, anticardiolipin antibodies, and anti-β2glycoprotein I antibodies (Oretel, 2012). It is estimated that APS may be responsible for nearly
one-third of cerebrovascular accidents in people under age 50 years, one-fifth of all cases of deep
vein thrombosis, and one-fourth of recurrent miscarriages. In its most life-threatening form,
catastrophic APS carries a mortality of 30-50%, even with treatment (Erkan & Pierangeli, 2012).
Although considered primarily a coagulopathy, APS may manifest as a complex systemic
autoimmune disease with diverse organ and tissue manifestations. It can occur alone or
secondary to other autoimmune disorders and has a particularly strong association with systemic
lupus erythematosus (Pullen, Vincent, & Siess, 2011). Despite its clinical implications and
prevalence, APS remains relatively unknown among healthcare professionals (Bulikova, 2012).
Background
Human cell membranes are composed primarily of fats called phospholipids (Marieb & Katja,
2010). These phospholipids are essential to the fluid structure and function of each cell and play
a major role in the clotting cascade (Bertolaccini, Ateka-Barrutia, & Khamashta, 2010).
Occasionally, due to medications, infections, malignancies, or underlying autoimmune disorders,
the body’s immune system forms antibodies, called antiphospholipid antibodies (aPLs), directed
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against epitopes on plasma proteins that are uncovered or created by the binding of these proteins
to phospholipids. These antibodies not only inhibit proteins critical to hemostasis and prevention
of thrombi formation, but also alter the complement pathways, thus creating a thrombogenic
state (Iwasawa, 2011).
Although many health professionals are not familiar with antiphospholipid syndrome (APS),
it is not rare. APS is the most commonly acquired thrombophilia and the most common treatable
cause of recurrent pregnancy loss. APS has a prevalence of 2-5% in the general population,
occurring more commonly in women than men with a 5:1 ratio (Biggioggero & Meroni, 2010).
Perinatal loss, estimated to occur in 15-20% of all pregnancies, is a distressing event
(Mathew, Cesario, & Symes, 2008). While 40% of pregnancy losses can be attributed to specific
causes, 60% of miscarriages are unexplained. Research has shown between 7%-25% of
unexplained fetal losses can be attributed to aPL antibodies (Vinatier, Dufour, Cosson, &
Houpeau, 2001). This makes APS the leading cause of unexplained fetal loss. In addition,
antiphospholipid antibodies are associated with 16% to 38% of fetal or embryonic deaths, 15%
to 30% of fetal growth restriction, and 18% of preeclampsia in all pregnancies (Buyon, 2009).
Despite APS’ clinical significance, research on nurses’ knowledge of APS and its nursing
management is limited. An extensive search of the literature using the electronic databases
Medline, CINAHL and PsychInfo discovered only one qualitative study on fetal loss related to
APS (Mathew, Cesario, & Symes, 2008), one qualitative study on patients’ experiences of
heparin therapy during pregnancy (Martins & Emed, 2007), two case studies (Kais-Wyllie, 2002;
Hilton, Reeves & Madavag, 1992), and two literature reviews (Vials, 2001; Ament 1994). To
date, no research has assessed nurses’ knowledge of APS or its nursing management. This is
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concerning since the qualitative study by Mathew, Cesario, & Symes (2008) showed that many
of the participants felt their diagnosis was delayed due to their healthcare providers’ lack of
knowledge regarding APS. In fact, many of the women blamed their providers for their
subsequent fetal loss due to a delay in diagnosis and treatment (Mathew, Cesario and Symes,
2008).
Perinatal nurses often care for pregnant women with APS who require treatment, education,
and support. Because of the prevalence of aPL antibodies and their associated adverse pregnancy
outcomes, it is imperative that nurses are aware of APS, its risks, associated complications,
medical treatment, and nursing management. Without this knowledge, nurses may fail to
anticipate or overlook subtle changes indicating pregnancy complications. Likewise, nurses may
not adequately educate their clients and their clients’ families regarding prevention and
management of APS complications.
The primary purpose of this study was to assess perinatal nurses’ knowledge of APS.
Additional goals of this study were to justify a larger study conducted at more than one site and
develop an educational intervention to inform nurses about APS and nursing care of patients with
APS.
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METHODS
This study was a cross sectional survey design. It was reviewed by the institutional review
board of the medical center where the study was conducted.
The researchers constructed a 20-item paper-and-pencil survey to assess demographic
information regarding age, education, work experience and knowledge of APS and its nursing
management of patients with APS. Eight questions covered demographics; twelve were
knowledge questions. Knowledge questions were constructed by a nurse practitioner with
experience in caring for patients with APS and who is the author of the Rheumatology Nurses
Society Core Curriculum chapter on APS (Weinstein, 2013). In addition, the questions were
reviewed by other content experts (obstetrician, rheumatologist and a nurse working in
obstetrics), thereby increasing its content validity. Knowledge items covered information on the
pathophysiology and diagnosis of APS, its medical treatment, and nursing management of
pregnant patients with APS.
Sample size was calculated to be 83, using a 15% margin of error, 95% confidence level and
50% response distribution, and drawing from a target population of 600 RNs. Eligibility criteria
for participation were age 18 years or older and employed as a registered nurse (RN) in Labor &
Delivery, NICU, Mother & Baby, Antepartum, or Obstetrical Triage.
The survey was administered in one of the nation’s busiest women and children’s hospital in a
metropolitan city in the Southeastern United States (Orlando Health, 2013). Ninety-three
registered nurses completed the survey within a 6-day period to limit discussion of the survey’s
content among staff. RNs who completed the survey received a $5 gift card in appreciation of
their time. After the surveys were completed, all data were entered into an Excel worksheet.
4

RESULTS
All analyses were conducted using IBM® SPSS® Statistics (2012). Descriptive statistics
were used to characterize the sample (Table 1). Ninety-two RNs completed the survey.
Participants represented staff from all units. All participants except one were female. Their mean
age was 41.5 years (±12.4). The entry level nursing education program for the majority of the
RNs (51.6%) was baccalaureate. On average, they had worked as an RN for 14 years (±12) and
in maternal health for 11.4 years (±10).
Table 1: Sample Characteristics

Age (year)

41.5 ± 12.4

Basic Nursing Education*
•
•
•

41 (44.1%)
3 (3.2%)
48 (51.6%)

ASN
3-year/Diploma degree
BSN

Highest Degree Attained
•
•

52 (55.9%)
5 (5.4%)

BSN
MSN

Employed as an RN (years)

14 ± 12

Years working in maternal
health
*N = 92

11.4 ± 10
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Table 2: Current areas of work among participants

Unit
Antepartum
Postpartum
Prenatal Clinic
Triage
NICU
Labor & Delivery

Number
10
42
10
6
20
5

Only 23.7% (N=20) of participants stated they were familiar with APS. The majority of
participants (75.4%, N=70) reported they were either unsure or unfamiliar with APS. Almost
13% reported having cared for a pregnant woman with APS, and 2.2% reported personally
knowing someone with APS.
Table 3: Participants’ familiarity with APS

Reported Familiarity
Cared for a Patient with APS
Personally Knew Someone
with APS

Yes
23.7%

No
55.9%

Unsure
19.4%

12.9%
2.2%

66.7%
93.5%

20.4%
4.3%

The majority of those nurses who responded that they were familiar with APS had reported
three primary sources for their information about APS: in-hospital education (7.5%), nursing
school (9.7%), and other (11.8%). Participants who marked “other” were given the opportunity
to write in where they had learned about the syndrome. Of the 10 participants who marked
“other”, 6 listed having cared for a patient with APS. One participant stated she had performed
an online search of APS because her patient was diagnosed with APS. Others reported their
knowledge came from various sources, such as rounds or while working on their specific unit.
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Table 4: Sources of information about APS

Source
Nursing School
Medical/Nursing conference/workshop
In-hospital education
Personal reading or research
Professional colleague
Other

Percentage
9.7%
1.1%
7.5%
2.2%
1.1%
11.8%

The mean score on the 8 knowledge items of the survey was 1.4 (±2) correct responses
(Figure 1). Most participants (57%) answered no questions correctly. The next largest group
(9.7%) answered two questions correctly.

Figure 1: Scores on knowledge items

Participants scored lowest on items about diagnostic criteria and pathophysiology of APS and
highest on items about clinical manifestations and postpartum care (Table 5).
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Table 5: Nurses’ Knowledge of Specific Areas

Questions (N)

Correct

Incorrect

Unfamiliar

Diagnostic Criteria (1)
Antiphospholipid
Antibodies (1)
Historical/Physical
Finding (2)
Obstetric
Complications
Nursing Assessment
of Complications
Patient Education
Postpartum Care

8.6%
6.5%

67.7%
19.4%

22.6%
73.1%

26.9%

1.1%

72%

20.4%

4.3%

75.3%

15.1%

14%

71%

22.6%
24.7%

7.5%
8.6%

69.9%
66.7%

A t test for independent samples showed significant (p <.000) differences in scores between
nurses who reported being familiar with APS (M=3.6±2.3) and those who were unfamiliar or
unsure about APS (.77±1.5). Nurses who considered themselves familiar with APS did score
higher, although the average score was below 50%.
Logistic regression was used to evaluate the effect of basic nursing education, highest nursing
degree attained, years of nursing experience, years working in maternal health, and current area
of work had on familiarity with APS. No variables were significant predictors for familiarity
with APS (𝑥 2 =4.273, df= 8, p> .832).
A one-way between groups analysis of variance (ANOVA) was conducted to explore the
impact of highest educational degree attained (3-yr, associate, baccalaureate and graduate) on
participants’ scores on the knowledge items. No statistical significance was found: F (3, 86) =
.517, p = .673.
An ANOVA also was conducted to explore the impact of current area of work (prenatal
clinic, triage, antepartum, labor and delivery, mother and baby/postpartum, and NICU) on
8

participants’ scores on the knowledge items. There was a statistically significant difference for
the six work areas at the p < .05 level in scores: F (5, 85) = 4.949, p = .001. The effect size,
calculated using eta squares, was large at .22 or 22%. Post hoc analysis using the Tukey HSD
indicated that the mean score of nurses working in triage was significantly higher than those
nurses working in postpartum and NICU. Since the group sizes were uneven, a risk of Type I
error exists.
The relationship between years working in maternal health and score on the 8 knowledge
items on the survey was investigated using Pearson product-moment correlation coefficient.
Preliminary analysis was performed to ensure no violations of assumptions revealed threats to
normality because of the uneven group sizes. Analyses were conducted nonetheless since the
sample size was large and this was a pilot study. There was a small, positive correlation between
the two variables, r = .28, n = 92, p =.007.
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DISCUSSION
The purpose of this study was to assess perinatal nurses’ knowledge regarding APS and its
nursing management. The majority of the nurses in this study (70%) were unfamiliar with APS.
Although those nurses familiar with APS had higher knowledge scores compared to those nurses
unfamiliar with the syndrome, the percentage of their correct responses was still less than 50%.
Educational background, years of nursing experience, years working in maternal health, or
current area of work did not predict familiarity. The only factor that significantly correlated with
higher scores was current area of work (p<.000), with nurses working in triage scoring the
highest. One could speculate that these nurses are the ones who are most likely to encounter
women who are at increased risk for, or are experiencing obstetrical complications related to,
APS. However, nurses working in prenatal clinics, including high-risk obstetrics, did not score
higher than nurses in other areas of maternal health. The fact that nurses who reported being
familiar with APS did score higher than those who were unfamiliar suggests that an educational
intervention could positively impact knowledge about APS.
It is not appropriate to blame nurses for lack of awareness about APS. Educational experience
and years working in nursing and/or maternal health were not associated with familiarity with
APS or knowledge scores. It appears that neither nursing academia nor the health system has
provided information about APS to nurses. Nurses who are aware of APS have picked it up as
part of their work experience. The majority of the nurses in this study who were familiar with
APS reported that their information about APS came from caring for patients with APS. About
13% of the nurses in the study first encountered this syndrome while working.
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Physicians and other health professionals as well as nurses often are unfamiliar with APS.
There may be a tendency to blame lack of knowledge about APS in the healthcare community on
the syndrome’s relative rarity. This is a common misconception in medicine in general
(Bulikova, 2012). APS is the most commonly acquired coagulopathy and the leading cause of
undiagnosed miscarriage and fetal loss (Erkan & Pierangeli, 2012). Dr. Graham Hughes, who
first described antiphospholipid syndrome (APS) and after whom Hughes syndrome is named,
believes that APS will become the most diagnosed autoimmune disorder of the 21st century
(Holden, 2003).
This study was the first to assess RNs’ knowledge of APS, so there are no other research
findings with which to compare results. However, the findings of this study are in line with the
results of the qualitative study by Mathew, Cesario, & Symes (2008) which concluded that
women with APS had an overwhelming feeling that their healthcare providers were not aware of
or knowledgeable about APS.
Limitations
All data were collected cross-sectionally from one medical center. Thus, any generalizations
related to the findings must be made with caution. However, this hospital delivers over 12,000
babies annually and is one of the busiest women’s hospitals in the country. Although recruitment
was aimed at achieving a sample representative of all areas within the medical center where the
study was conducted, some areas were more represented than others. As a consequence,
homogeneity of variance was threatened and may have affected ANOVA results. The knowledge
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items on the survey were created by health professionals familiar with APS and content validity
is justified, but no attempt was made at determining reliability or additional measures of validity.
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CONCLUSION
Nurses play an integral role in the assessment and care of all patients. Educational efforts to
increase awareness of APS and its nursing management have the potential to improve pregnancy
outcomes and minimize postpartum risk in women with APS. Maternal health nurses who
understand the complications of APS and its manifestations may be better able to quickly
identify historical/physical findings that could alert them to the possibility of an embolic event or
obstetrical complication.
The findings from this study justify a larger study at multiple sites that would determine
specific educational needs of nurses in regards to APS. Likewise, this study points out the need
for a reliable and valid tool to assess knowledge of APS. The ultimate goal would be to develop
and test an educational intervention on APS for nurses, not only in maternal health, but other
areas as well since APS is not limited to pregnant women.
With increased awareness of APS, nurses have the potential to swiftly identify manifestations
of a thrombotic event or obstetric complication and decrease the time between symptom onset
and treatment. Just as importantly, nurses’ role as patient advocates and educators allow them to
empower patients with APS with the self-care tools that decrease their risk for embolic events
and poor pregnancy outcomes. Given the consequences of untreated APS, educating nurses about
APS is a more than worth the effort.
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APPENDIX: SURVEY
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1. Birthdate: _____________
YEAR ONLY

2. Gender:  Female

3. Basic nursing education (entry into nursing profession)
Associate degree
 3-year/diploma degree

 Male

 Bachelor of nursing degree

4. Year of graduation from basic nursing program (above) _____________
5. Highest nursing degree attained
 Associate degree
 3-year/diploma degree
 Master of nursing degree  Bachelor of nursing degree

 Bachelor of nursing degree
 DNP/PhD

6. Number of years employed as a nurse __________
7. Number of years working in maternal (prenatal, labor & delivery, postpartum, neonatal
intensive care) nursing _____
8. Current area where you work primarily:
 Prenatal clinic
 Triage
 Labor & Delivery
NICU

Mother & Baby/Postpartum

9. Are you familiar with antiphospholipid antibody syndrome/Hughes Syndrome?
 Yes No  Unsure
10. Have you personally cared for a pregnant woman with antiphospholipid antibody syndrome?
 Yes No  Unsure
11. Do you or anyone you personally know have antiphospholipid antibody syndrome?
 Yes  No  Unsure
12. Where did you first learn about antiphospholipid antibody syndrome?
 nursing school
 medical/nursing conference/workshop  in-hospital education
 personal reading or research  professional colleague
 other____________________________________________________________________
 I am unfamiliar with antiphospholipid antibody syndrome

Please check ONE answer for each of the following questions:
13. Which one of the following manifestations would meet diagnostic criteria for
antiphospholipid syndrome?
 a. Thrombocytopenia
 b. Anti-prothrombin antibody
 c. Livedo reticularis
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 d. Pulmonary embolism
 d. I am unfamiliar with diagnostic criteria for antiphospholipid syndrome
14. Which of the following is considered an antiphospholipid antibody?
 a. Lupus anticoagulant
 b. Anti-platelet factor
 c. Anti-phospholipidase
 d. Anti-double stranded DNA
 e. I am unfamiliar with antiphospholipid antibodies
15. Which of the following historical or physical findings in a patient would alert you to the
possibility of antiphospholipid antibody syndrome?
 a. Hyperemesis gravidarum
 b. Unexplained second or third trimester fetal death
 c Hydatidiform mole
 d. Incompetent cervical os
 e. I am unfamiliar with the historical or physical findings of antiphospholipid antibody
syndrome
16. Which of the following complications is associated with antiphospholipid syndrome in
pregnant women?
 a. Fetal growth restriction
 b. Post-term/overdue pregnancy
 c. Prolonged labor
 d. Neonatal heart block
 e. I am unfamiliar with pregnancy complications associated with antiphospholipid antibody
syndrome
17. Which one of the following medical treatments would you expect in a pregnant woman with
antiphospholipid antibody syndrome?
 a. Low dose aspirin
 b. Coumadin (Warfarin)
 c. Dabigatrin (Pradaxa)
 d. Immunosuppressive therapy
 e. I am unfamiliar with treatment for antiphospholipid antibody syndrome
18. Which one of the following symptoms/manifestations by a patient with antiphospholipid
syndrome should most concern the nurse?
 a. Severe headache of sudden onset
 b. Platelet count of 140,000/mm3
 c. Fever of 100°F
 d. Fatigue
 e. I am unfamiliar with symptoms/manifestations associated with antiphospholipid
syndrome
16

19. A 26-year-old woman with antiphospholipid syndrome delivered her first child one day ago
and you are preparing to discharge her. She asks you about birth control methods. Which
one of the following would you NOT recommend?
 a. Diaphragm with spermicidal cream
 b. Low-dose estrogen birth control pills
 c. Condoms
 d. Intrauterine device
 e. I am unfamiliar with recommended birth control methods for patients with
antiphospholipid antibody syndrome
20. A 26-year-old woman with lupus and antiphospholipid syndrome delivered her first child
one day ago and you are preparing to discharge her. Which one of the following discharge
medications would you most likely anticipate her to be on for the next 6-8 weeks?
 a. Prednisone
 b. Methotrexate
 c. Low molecular weight heparin (LMWH)
 d. Low-dose estrogen birth control pills
 e. I am unfamiliar with postpartum medications for patients with lupus and
antiphospholipid antibody syndrome

Thank you for completing this questionnaire.
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